World's drug bill will reach US$1.3t by 2018: study
New York
WORLDWIDE spending on medicines will reach almost US$1.3 trillion by 2018, as new treatments for hepatitis C and cancer come to market and as people around the globe use rising incomes to buy pharmaceuticals.
The new drugs, such as Gilead Sciences Inc's US$1,000-per-pill hepatitis C treatment, will help drive the increase in spending up 30 per cent from 2013 levels, according to a report published on Thursday by the IMS Institute for Healthcare Informatics, the research arm of IMS Health Holdings Inc, which tracks drug prescriptions and sells the data.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Chinese tariffs could leave cognac makers with too much brandy
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
WSJ moves Asia headquarters from Hong Kong to Singapore
South Korea to slap fines on food suppliers for ‘shrinkflation’
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Live Nation’s revenue beats estimates as boom in concerts drive ticket sales